 |
|
Oral Erosive Lichen Planus Treated With Efalizumab
Amy Cheng, MD;
Caroline Mann
Washington University, School of Medicine, St Louis, Mo
Arch Dermatol. 2006;142:680-682.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
REPORT OF A CASE
A 54-year-old white woman presented with a 3-month history of progressive painful lesions on her tongue and oral mucosa. Her primary care physician initially treated her with nystatin and hydrogen peroxide, followed a few weeks later by acyclovir (Zovirax) ointment and a rapid 5-day prednisone taper, without improvement in her symptoms. Two months after the oral lesions developed, violaceous papules began to appear on her body as well. The week before presentation, she complained of difficulty in swallowing pills because of the pain associated with her oral lesions. She did not have a history of liver disease or hepatitis. A review of systems revealed no recent weight changes, fevers, or chills, and except for the symptoms mentioned above, the findings were otherwise unremarkable.
Physical examination demonstrated excoriated erythematous papules and plaques on the bilateral aspect of the arms and on the chest, back, and lower . . . [Full Text of this Article]
THERAPEUTIC CHALLENGE
SOLUTION
COMMENT
AUTHOR INFORMATION
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Mucocutaneous Lichen Planus With Esophageal Involvement: Successful Treatment With an Anti-CD20 Monoclonal Antibody
Parmentier et al.
Arch Dermatol 2008;144:1427-1430.
FULL TEXT
|
